Novel Supplement Based Therapy
SIBO-ATRGM2017
Phase 1 other terminated
Quick answer
Novel Supplement Based Therapy for Small Intestinal Bacterial Overgrowth is a Phase 1 program (other) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atrium Therapeutics
- Indication
- Small Intestinal Bacterial Overgrowth
- Phase
- Phase 1
- Modality
- other
- Status
- terminated